市場データを読み込み中...
2026年8月7日金曜日
すべての企業
Kimberly-Clark logo

Kimberly-ClarkKMB

U.S. LISTED生活必需品kimberly-clark.com

この企業紹介の日本語訳は準備中です。以下は英語の原文です。

Kimberly-Clarkについて

Kimberly-Clark Corporation manufactures and sells personal care and consumer tissue products under a portfolio of household brands including Huggies, Pull-Ups, Kotex, Depend, Poise, Kleenex, Cottonelle, Scott, and Viva. The business is organized around three reportable segments: Personal Care, which sells diapers, training pants, feminine care and adult incontinence products; Consumer Tissue, which sells facial and bathroom tissue, paper towels and napkins for household use; and K-C Professional, which supplies washroom, wiping and safety products to away-from-home markets such as offices, manufacturing plants, healthcare facilities and food service. Personal Care is typically the largest contributor to both revenue and operating profit, with Consumer Tissue the volume anchor and K-C Professional the higher-margin B2B channel.

Investors track a recurring set of structural questions. Input cost exposure is central because pulp, superabsorbent polymers, resin and energy move with global commodity cycles and directly compress or expand gross margin. Retail customer concentration matters, since a meaningful share of sales flows through a handful of mass merchants, warehouse clubs and grocery chains that hold pricing leverage and increasingly promote private-label alternatives. Foreign exchange translation is a persistent line item given the geographic footprint, and emerging-market currency swings can distort reported growth. Capital allocation is closely watched: the company has a long dividend record, uses buybacks alongside restructuring programs, and carries the governance profile of a mature S&P 500 consumer staple.

The company traces its origins to 1872, when John A. Kimberly, Charles B. Clark and two partners founded a paper mill in Neenah, Wisconsin. It pioneered cellulose wadding during the First World War, which led to Kotex feminine napkins in 1920 and Kleenex facial tissue in 1924, transforming a regional paper maker into a branded consumer products company. A transformative 1995 combination with Scott Paper Company added the Scott and Cottonelle tissue franchises and materially expanded the international footprint. In 2014 Kimberly-Clark spun off its healthcare business as Halyard Health, sharpening focus on consumer and professional categories. The company is incorporated in Delaware, headquartered in the Dallas, Texas area, and its shares trade on the New York Stock Exchange.

Revenue is generated primarily through sales to retailers and distributors rather than directly to end users. Personal Care and Consumer Tissue reach shoppers through mass merchandisers, grocery, drug, warehouse clubs, e-commerce platforms and, in many international markets, traditional trade; K-C Professional sells through distributors to institutional buyers under contracts that bundle products with dispensing systems. Competitive position rests on brand equity built over decades, scale in pulp-based manufacturing, distribution reach and continuous product innovation in areas such as absorbency and sustainable materials. Principal rivals include Procter & Gamble in diapers and feminine care, Essity and Georgia-Pacific in tissue and away-from-home, and a growing tier of regional and private-label producers. International markets contribute a substantial share of total sales, with developing and emerging economies a long-standing growth focus.

企業プロフィールはLineVest編集部によるものです。ジャーナリズムであり、投資助言ではありません。 Kimberly-ClarkのSECベース詳細レポートを依頼 →

Kimberly-Clark関連記事

Kimberly-Clarkの記事はまだありません — LineVestは米国市場ニュースを毎日発行しており、Kimberly-Clarkの新しい記事は自動的にここに表示されます。

最新の米国市場ニュースを見る →

見出しの先を読む

何が起きたかは読みました。次は、それが何を意味するかを。

無料デイリーブリーフィング

米国市場を毎朝 — 無料で

LineVest Dailyが寄付き前に届きます:米国市場の主要ストーリー、決算、開示、外国人フロー — わかりやすい英語で。無料、カード登録不要。

LineVest Dailyを無料で →
この企業

Kimberly-Clarkの詳細レポート

Kimberly-Clarkの最新SEC開示を全て読み込みます — US GAAPの財務、ガバナンス、株価への意味まで。3時間以内にPDFでお届け。

$12・買い切り

Kimberly-Clarkレポートを入手
ウォッチ銘柄すべて

市場全体をフォロー

週に何銘柄も米国株を見ていますか?すべての分析記事を公開と同時に — デイリーの米国市場全カバレッジと90日アーカイブ。

$9.99・月額

購読する

一次資料のSEC開示に基づく独立ジャーナリズム — 投資助言ではありません。証券会社との提携はありません。